Trial Details
TERMINATEDBasic Information
| Clinical ID | c1512 |
|---|---|
| Identifier | NCT04064697 |
| Trial Title | Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis, Unspecified |
| Interventions | DRUG: Valganciclovir |
Participant Information
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
|---|---|
| City | Annecy |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-04-22 |
|---|---|
| Primary Completion Date | 2023-11-23 |
| Completion Date | 2024-02-08 |